Tag: Medical

Vivani
Global, United States

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Appointment comes as Vivani prioritizes the development of its GLP-1 implants for the treatment of obesity and chronic weight management Under Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured in 2012 approval of Bydureon® (exenatide injection), the world’s first once-weekly GLP-1 receptor agonist, a class of drugs that now includes blockbusters Ozempic®, Trulicity®, and Wegovy® ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or … Continue reading Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Impact Newswire
Cagent Vascular
Global, United States

Cagent Vascular Raises $30 Million Series C Financing

Funds will be used to accelerate US market adoption and to expand the product portfolio of the first and only Serration Angioplasty Technology WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M. U.S. Venture Partners (USVP), led the round. Participation included new investor Blue Ridge Medical, LLC and existing investors, … Continue reading Cagent Vascular Raises $30 Million Series C Financing

Impact Newswire
QuidelOrtho
Global, United States

QuidelOrtho Announces Changes in Executive Leadership

The Board of Directors has terminated President and Chief Executive Officer, Douglas Bryant and appointed, on an interim basis, Michael Iskra as Chief Executive Officer and Robert Bujarski as President SAN DIEGO–(BUSINESS WIRE)–The Board of Directors (the “Board”) of QuidelOrtho Corporation (Nasdaq: QDEL) (the “Company” or “QuidelOrtho”) has made significant decisions aimed to enhance operational efficiency, drive revenue growth and deliver shareholder value. “All of … Continue reading QuidelOrtho Announces Changes in Executive Leadership

Impact Newswire
MMI (MEDICAL MICROINSTRUMENTS, INC.)
Europe, Global

MMI Raises $110 Million in Series C Financing

Largest ever investment in microsurgery will further MMI’s mission to transform open surgery with robotic technology JACKSONVILLE, Fla.–(BUSINESS WIRE)–MMI (Medical Microinstruments, Inc.), a robotics company dedicated to increasing treatment options and improving clinical outcomes for patients with complex conditions, today announced that it has raised $110 million in Series C financing. The round, led by Fidelity Management & Research Company, marks the largest ever investment in … Continue reading MMI Raises $110 Million in Series C Financing

Impact Newswire
Amplitude Vascular Systems
Global, United States

AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Global executive will lead the clinical research strategy and execution for pulse intravascular lithotripsy BOSTON–(BUSINESS WIRE)–AVS (Amplitude Vascular Systems, Inc), an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced the appointment of Elizabeth Galle as the company’s new Vice President of Clinical Affairs. She comes to AVS with more than two decades of leadership experience … Continue reading AVS Appoints Elizabeth Galle as Vice President of Clinical Affairs

Impact Newswire
CroíValve
Europe, Global

CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Additionally, Martin B. Leon, M.D. Appointed as Chair of its Clinical Advisory Board DUBLIN–(BUSINESS WIRE)– CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study to … Continue reading CroíValve Announces FDA IDE Approval and Initiation of its Early Feasibility Study

Impact Newswire
AtriCure
Global, United States

AtriCure Appoints Shlomi Nachman to the Board of Directors

January 04, 2024 08:00 AM Eastern Standard Time MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced it appointed Shlomi Nachman to its Board of Directors. Mr. Nachman’s long and distinguished career in the medical device industry has placed him at the forefront of new … Continue reading AtriCure Appoints Shlomi Nachman to the Board of Directors

Impact Newswire
Moximed
Global, United States

Moximed Announces Appointment of Dave Amerson to Board of Directors

Amerson has demonstrated commercial leadership of multiple early-stage medical device technologies with nearly $3 billion in transaction value for investors FREMONT, Calif.–(BUSINESS WIRE)–Moximed, a medical device company on a mission to improve the standard of care for people with knee osteoarthritis (OA), today announced that Dave Amerson has joined the company’s Board of Directors. “I am thrilled to join Moximed’s Board of Directors at this … Continue reading Moximed Announces Appointment of Dave Amerson to Board of Directors

Impact Newswire